Picture of Santhera Pharmaceuticals Holding AG logo

SANN — Santhera Pharmaceuticals Holding AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Santhera Announces Launch Of Early Access Program In China For Agamree By Its Partner Sperogenix

June 10 (Reuters) - Santhera Pharmaceuticals Holding AG
 SANN.S :
    * SANTHERA ANNOUNCES LAUNCH OF EARLY ACCESS PROGRAM IN CHINA
FOR
AGAMREE® BY ITS PARTNER SPEROGENIX
    * SANTHERA PHARMACEUTICALS HOLDING AG - SUBJECT TO A
POSITIVE
REVIEW OUTCOME, APPROVAL COULD BE OBTAINED BY Q1-2025

Source text for Eikon:  ID:nGNXb913Yg 
Further company coverage:  SANN.S 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Santhera Pharmaceuticals Holding AG

See all news